TREATABLE TRAITS, TAILORED CARE: Targeting Type 2 Inflammation, Enhancing Diagnostic Accuracy, and Promoting Patient Collaboration in COPD MANAGEMENT
A MECC-Organized Symposium at the ATS 2026 International Conference. An evening symposia educational program sponsored by Med Learning Group and supported by a grant from GSK open to all ATS 2026 International Conference attendees.
Monday, May 18, 2026
6:45 PM – 8:15 PM ET
5:45 PM – 7:15 PM CT
4:45 PM – 6:15 PM MT
3:45 PM – 5:15 PM PT
Features
- Interactive case-based presentation
- Downloadable whiteboard animations
- Online personalized quality-improvement poster-generation portal
Program Overview
This satellite symposium is designed for pulmonologists and advanced practice providers who care for patients with chronic obstructive pulmonary disease (COPD). The program will explore the underlying pathophysiology of COPD, with a particular focus on the role of type 2 inflammatory pathways in disease development and progression.
Participants will gain insights into how disease phenotypes, biomarkers, and treatable traits can inform a COPD diagnosis and guide individualized treatment planning. The symposium will also emphasize the importance of aligning treatment decisions with clinical guidelines while incorporating the patient perspective and fostering multidisciplinary collaboration to optimize care.
Learning Objectives
- Summarize the pathophysiologic mechanisms, including the role of type 2 inflammatory pathways, underlying COPD development and progression
- Incorporate disease phenotypes, biomarkers, and treatable traits into COPD diagnostic and treatment planning discussions
- Construct guideline-informed COPD treatment plans that integrate the patient perspective and multidisciplinary care
Target Audience
This educational activity is intended for pulmonologists and pulmonology advanced practice providers involved in the care of patients with COPD.
Joint Accreditation Statement
Physician Credit Designation Statement
Med Learning Group designates this live activity for a maximum of 1.50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the live activity.
Nurses (ANCC) Credit Designation
Med Learning Group designates this activity for a maximum of 1.50 ANCC contact hours.
ACCME Innovation Partner
Med Learning Group (MLG) is proud to be recognized as an ACCME Innovation Partner, leading the way in simplifying CME for physicians. As an Innovation Partner, MLG will be working with the ACCME by submitting credits directly to CME Passport.
PHYSICIAN DISCLAIMER: Upon your acceptance in the evaluation and completion of this CME activity, Med Learning Group will share your completion information and certain personal details (e.g., name, National Provider Identifier, birthdate MM/DD) with the ACCME for inclusion in your CME Passport transcript and, as applicable, reporting to certifying, licensing, or other regulatory authorities you specify.
Disclosure Policy Statement
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
Disclosure Of Unlabeled Use
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
Disclaimer
Med Learning Group makes every effort to develop CE activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use. For CE questions, please contact Med Learning Group at info@medlearninggroup.com
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at https://www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at info@medlearninggroup.com
Release date: May 18, 2026
Expiration date: May 18, 2026
Estimated time to completion: 1.5 hours
